Prajakta Badri

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

Paul Y. Kwo, Parvez Mantry, Eoin Coakley et al. · New England Journal of Medicine · 2014 · 402 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

David Adams, Ivailo Tournev, Mark Taylor et al. · Amyloid · 2022 · 379 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

Mathew S. Maurer, Parag Kale, Marianna Fontana et al. · New England Journal of Medicine · 2023 · 307 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +7

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir

Rajeev Menon, Prajakta Badri, Tianli Wang et al. · Journal of Hepatology · 2015 · 125 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT-450, Ombitasvir, and Dasabuvir

Prajakta Badri, Sheetij Dutta, Eoin Coakley et al. · American Journal of Transplantation · 2015 · 84 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17